- Home
- FDMT vs CTKB Comparison
FDMT vs CTKB Comparison
Compare FDMT & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- CTKB
- Stock Information
- Founded
- FDMT 2013
- CTKB 1990
- Country
- FDMT United States
- CTKB United States
- Employees
- FDMT N/A
- CTKB N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FDMT Health Care
- CTKB Health Care
- Exchange
- FDMT Nasdaq
- CTKB Nasdaq
- Market Cap
- FDMT 391.8M
- CTKB 433.8M
- IPO Year
- FDMT 2020
- CTKB 2021
- Fundamental
- Price
- FDMT $9.97
- CTKB $4.01
- Analyst Decision
- FDMT Strong Buy
- CTKB Hold
- Analyst Count
- FDMT 8
- CTKB 4
- Target Price
- FDMT $30.63
- CTKB $6.00
- AVG Volume (30 Days)
- FDMT 771.6K
- CTKB 841.7K
- Earning Date
- FDMT 11-12-2025
- CTKB 11-04-2025
- Dividend Yield
- FDMT N/A
- CTKB N/A
- EPS Growth
- FDMT N/A
- CTKB N/A
- EPS
- FDMT N/A
- CTKB N/A
- Revenue
- FDMT $33,000.00
- CTKB $196,035,000.00
- Revenue This Year
- FDMT $9,656.76
- CTKB N/A
- Revenue Next Year
- FDMT N/A
- CTKB $7.25
- P/E Ratio
- FDMT N/A
- CTKB N/A
- Revenue Growth
- FDMT N/A
- CTKB N/A
- 52 Week Low
- FDMT $2.24
- CTKB $2.37
- 52 Week High
- FDMT $10.03
- CTKB $7.63
- Technical
- Relative Strength Index (RSI)
- FDMT 69.13
- CTKB 57.22
- Support Level
- FDMT $8.50
- CTKB $3.75
- Resistance Level
- FDMT $10.03
- CTKB $4.04
- Average True Range (ATR)
- FDMT 0.64
- CTKB 0.19
- MACD
- FDMT 0.07
- CTKB 0.04
- Stochastic Oscillator
- FDMT 86.96
- CTKB 96.15
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.